"Hay esperanza porque este fármaco funciona mejor que cualquier otro”: un experto de Harvard celebró un avance clave contra el cáncer de páncreas

A researcher from Harvard Medical School has praised a key medical advancement in the treatment of pancreatic cancer, describing a newly approved drug as performing better than any predecessor.

The expert expressed strong optimism regarding the future of oncology, predicting that the clinical management and treatment landscape for pancreatic cancer will become unrecognizable within the next decade due to this pharmaceutical development.